These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Targeting endothelial glycolytic reprogramming by tsRNA-1599 for ocular anti-angiogenesis therapy. Han XY; Kong LJ; Li D; Tong M; Li XM; Zhao C; Jiang Q; Yan B Theranostics; 2024; 14(9):3509-3525. PubMed ID: 38948065 [No Abstract] [Full Text] [Related]
9. Antiangiogenic Potential of Microbial Metabolite Elaiophylin for Targeting Tumor Angiogenesis. Lim HN; Jang JP; Han JM; Jang JH; Ahn JS; Jung HJ Molecules; 2018 Mar; 23(3):. PubMed ID: 29498688 [TBL] [Abstract][Full Text] [Related]
10. Brag2 differentially regulates β1- and β3-integrin-dependent adhesion in endothelial cells and is involved in developmental and pathological angiogenesis. Manavski Y; Carmona G; Bennewitz K; Tang Z; Zhang F; Sakurai A; Zeiher AM; Gutkind JS; Li X; Kroll J; Dimmeler S; Chavakis E Basic Res Cardiol; 2014 Mar; 109(2):404. PubMed ID: 24522833 [TBL] [Abstract][Full Text] [Related]
11. Antiangiogenic effect of betaine on pathologic retinal neovascularization via suppression of reactive oxygen species mediated vascular endothelial growth factor signaling. Park SW; Jun HO; Kwon E; Yun JW; Kim JH; Park YJ; Kang BC; Kim JH Vascul Pharmacol; 2017 Mar; 90():19-26. PubMed ID: 27473515 [TBL] [Abstract][Full Text] [Related]
12. Suppression of alpha-tocopherol ether-linked acetic acid in VEGF-induced angiogenesis and the possible mechanisms in human umbilical vein endothelial cells. Chuang CH; Liu CH; Lu TJ; Hu ML Toxicol Appl Pharmacol; 2014 Dec; 281(3):310-6. PubMed ID: 25447407 [TBL] [Abstract][Full Text] [Related]
13. Endothelial microRNA-150 is an intrinsic suppressor of pathologic ocular neovascularization. Liu CH; Sun Y; Li J; Gong Y; Tian KT; Evans LP; Morss PC; Fredrick TW; Saba NJ; Chen J Proc Natl Acad Sci U S A; 2015 Sep; 112(39):12163-8. PubMed ID: 26374840 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of vascular endothelial growth factor-induced angiogenesis by scopoletin through interrupting the autophosphorylation of VEGF receptor 2 and its downstream signaling pathways. Pan R; Dai Y; Gao XH; Lu D; Xia YF Vascul Pharmacol; 2011; 54(1-2):18-28. PubMed ID: 21078410 [TBL] [Abstract][Full Text] [Related]
15. Isoliquiritigenin from licorice root suppressed neovascularisation in experimental ocular angiogenesis models. Jhanji V; Liu H; Law K; Lee VY; Huang SF; Pang CP; Yam GH Br J Ophthalmol; 2011 Sep; 95(9):1309-15. PubMed ID: 21719569 [TBL] [Abstract][Full Text] [Related]
16. miR-342-5p Is a Notch Downstream Molecule and Regulates Multiple Angiogenic Pathways Including Notch, Vascular Endothelial Growth Factor and Transforming Growth Factor β Signaling. Yan XC; Cao J; Liang L; Wang L; Gao F; Yang ZY; Duan JL; Chang TF; Deng SM; Liu Y; Dou GR; Zhang J; Zheng QJ; Zhang P; Han H J Am Heart Assoc; 2016 Feb; 5(2):. PubMed ID: 26857067 [TBL] [Abstract][Full Text] [Related]
17. Formononetin, a novel FGFR2 inhibitor, potently inhibits angiogenesis and tumor growth in preclinical models. Wu XY; Xu H; Wu ZF; Chen C; Liu JY; Wu GN; Yao XQ; Liu FK; Li G; Shen L Oncotarget; 2015 Dec; 6(42):44563-78. PubMed ID: 26575424 [TBL] [Abstract][Full Text] [Related]
18. Sustained intraocular vascular endothelial growth factor neutralisation does not affect retinal and choroidal vasculature in Ins2 Lechner J; Hombrebueno JR; Pedrini E; Chen M; Xu H Diab Vasc Dis Res; 2019 Sep; 16(5):440-449. PubMed ID: 31023085 [TBL] [Abstract][Full Text] [Related]
19. A novel antiangiogenic peptide derived from hepatocyte growth factor inhibits neovascularization in vitro and in vivo. Xu Y; Zhao H; Zheng Y; Gu Q; Ma J; Xu X Mol Vis; 2010 Oct; 16():1982-95. PubMed ID: 21031024 [TBL] [Abstract][Full Text] [Related]
20. Prolyl 3-Hydroxylase 2 Is a Molecular Player of Angiogenesis. Pignata P; Apicella I; Cicatiello V; Puglisi C; Magliacane Trotta S; Sanges R; Tarallo V; De Falco S Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33918807 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]